This is a working overview of anti-doping, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-07-25. Anything still debated is marked as such rather than presented as settled.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
Laboratory identification of SR9009 typically relies on chromatographic separation coupled to mass spectrometry, often with ultraviolet detection as a secondary check. Nuclear magnetic resonance spectroscopy can confirm molecular structure when a reference standard is available. Because many suppliers sell the compound as a research chemical, independent identity testing is important for experimental reproducibility. A single retention time is not sufficient proof of identity, especially when related compounds may be present. Purity assessments usually report a percentage based on area normalization.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Visual inspection is not sufficient for identity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water; stock solutions use organic solvent. |
| Storage | -20°C, desiccated, protected from light | Limits hydrolysis and photodegradation. |
| Analytical method | HPLC-UV/MS | Used for identity and purity assessment. |
| Synonyms | SR9009, Stenabolic | Naming varies by supplier. |
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Forty-six Israeli civilians, 28 soldiers and one security officer were killed in Hezbollah's attacks on Israel. An additional three soldiers were killed in non-combat incidents; one by malfunctioning ammunition and the other two in a tank accident. Forty-seven soldiers, including a civilian researcher posthumously recognized as a soldier, were killed during combat in southern Lebanon. Hezbollah's attacks resulted in the evacuation of over 90,000 people—60,000 forced and 30,000 voluntary—from northern Israel. As of July 2024, the Israeli government issued orders for the evacuation of 43 settlements located within 3 miles (4.8 km) of the border with Lebanon. At least eight Israeli UAVs were shot down over Lebanon: four Hermes 450 and four Hermes 900 models. According to the Israeli Army Radio, 2,874 buildings have been reported damaged by Hezbollah, including 841 in need of rebuilding. Property damage was estimated to be around ₪1 billion (US$273 million). As of November 2024, over 60% of the buildings in Metula were destroyed by Hezbollah attacks since the start of the conflict. Three-fourths of the buildings in Manara, 382 buildings in Kiryat Shmona, and 55,000 acres of nature in northern Israel and the Golan Heights have been damaged or destroyed by Hezbollah's attacks, while major damage also took place in Nahariya and Shlomi.
==== Rare-earth mining ==== Due to natural occurrence of radioactive elements such as thorium and radium in rare-earth ore, mining operations also result in production of waste and mineral deposits that are slightly radioactive.
=== Chemotherapy-induced neutropenia === Chemotherapy can cause myelosuppression and unacceptably low levels of white blood cells (leukopenia), making patients susceptible to infections and sepsis. G-CSF stimulates the production of granulocytes, a type of white blood cell. In oncology and hematology, a recombinant form of G-CSF is used with certain cancer patients to accelerate recovery and reduce mortality from neutropenia after chemotherapy, allowing higher-intensity treatment regimens. It is administered to oncology patients via subcutaneous or intravenous routes. A QSP model of neutrophil production and a PK/PD model of a cytotoxic chemotherapeutic drug (Zalypsis) have been developed to optimize the use of G-CSF in chemotherapy regimens with the aim to prevent mild-neutropenia. G-CSF was first trialled as a therapy for neutropenia induced by chemotherapy in 1988. The treatment was well tolerated and a dose-dependent rise in circulating neutrophils was noted. A study in mice has shown that G-CSF may decrease bone mineral density. G-CSF administration has been shown to attenuate the telomere loss associated with chemotherapy.
Sources: en.wikipedia.org
The Gallery of Palaeontology and Comparative Anatomy was built between 1894 and 1897 by architect Ferdinand Dutert, who had built the innovative iron-framed Galerie des machines at the 1889 Paris Exposition. A new pavilion in the same style was added to the west side of the gallery; it was completed in 1961. In front of the Gallery is the Iris Garden, created in 1964, which displays 260 varieties of iris flowers, and a sculpture, "Nymph with a pitcher" (1837) by Isidore Hippolyte Brion. The sides of gallery are also decorated with sculpture; twelve relief sculptures of animals in bronze and fourteen medallions of famous biologists. The ironwork grill and stone arches over the entrance are filled with elaborate designs and sculpture of seashells. Inside the entrance is a large marble statue of an Orangutan strangling a hunter, created in 1885 by the noted animal sculptor Emmanuel Fremiet, best known for his statue of Joan of Arc on horseback on the Place des Pyramides in Paris.
The presence of autoantibodies against citrullinated proteins in rheumatoid arthritis patients was first described in the mid-1970s when the biochemical basis of antibody reactivity against keratin and filaggrin was investigated. Subsequent studies demonstrated that autoantibodies from RA patients react with a series of different citrullinated antigens, including fibrinogen, deiminated Epstein–Barr virus nuclear antigen 1 and vimentin, which is a member of the intermediate filament family of proteins. Several assays for detecting ACPAs were developed in the following years, employing mutated citrullinated Vimentin (MCV-assay), filaggrin-derived peptides (CCP-assay) and viral citrullinated peptides (VCP-assay). A 2006 clinical study showed that anti viral citrullinated peptide (VCP) antibodies of the IgG and IgA isotypes represent a discriminating specific marker of rheumatoid arthritis from other chronic arthritides and disease controls, suggesting an independent production of each isotype. In 2010, ACPA testing has become substantial part of The 2010 ACR-EULAR classification criteria for rheumatoid arthritis.
Moreover, the absolute uranium concentrations indicate that there was no contamination of the earthworm species studied." Though a more comprehensive assessment is possible, a 2011 update on a cancer scare regarding Italian soldiers who had served in the Balkans found lower than expected incidence rates for all cancers, a finding "consistent with lacking evidence of an increased cancer incidence among troops of other countries deployed in the areas of Iraq, Bosnia, and Kosovo, where armour-penetrating depleted uranium shells have been used." In 2018, Serbia set up a commission of inquiry into the consequences of the use of depleted uranium during the 1999 NATO bombing of Yugoslavia in southern Serbia and its link to the rise of diseases and tumors among citizens, particularly in young children born after 1999. Zoran Radovanovic, an epidemiologist and the chairman of the Serbian Medical Association's ethics committee, denied that there had been a rise in cancer cases in areas where bombings had taken place. He continued by saying that Serbians frequently worry about a cancer epidemic that does not exist. NATO has repeatedly claimed that depleted uranium found in the ammunition used in the 1999 bombardments cannot be linked to adverse health effects.
Sources: en.wikipedia.org
HbO2 + CO ⇌ Hb(CO) + O2 is established in the blood of cigarette smokers. Chelation therapy is based on the principle of using chelating ligands with a high binding selectivity for a particular metal to remove that metal from the human body. Complexes with polyamino carboxylic acids find a wide range of applications. EDTA in particular is used extensively.
In addition to the primary methods above, another method exists to measure the moisture content of wood: an electronic moisture meter. Pin and pinless meters are the two main types of moisture meters. Pin meters require driving two pins into the surface of the wood while making sure that the pins are aligned with the grain and not perpendicular to it. Pin meters provide moisture content readings by measuring the resistance in the electrical current between the two pins. The drier the wood, the more resistance to the electrical current, when measuring below the fiber saturation point of wood. Pin meters are generally preferred when there is no flat surface of the wood available to measure Pinless meters emit an electromagnetic signal into the wood to provide readings of the wood's moisture content and are generally preferred when damage to the wood's surface is unacceptable or when a high volume of readings or greater ease of use is required.
Control is a standard against which experimental observations may be evaluated. In clinical trials, one group of participants is given an experimental drug, while another group (i.e., the control group) is given either a standard treatment for the disease or a placebo. (NLM) Coordinating Committee
=== Religion === Galloway has been outspoken in support of religious liberties. Though he has long stated that his religious beliefs are a private matter, Galloway was raised, and in 2016, said that he was a Roman Catholic Christian. In a 2013 interview, Galloway sparked controversy for saying as a Roman Catholic, he would not feel safe in an independent Scotland given the historically bigoted views harboured by many Scottish nationalists towards Catholics. At a 2012 rally, he said: "We stand for justice and haqq" and "A Muslim is somebody who is not afraid of earthly power but who fears only the Judgment Day. I'm ready for that, I'm working for that and it's the only thing I fear." In April 2012 Jemima Khan claimed Galloway had converted to Islam around 2000 and that his shahadah was performed in Kilburn, London. Galloway denied the claims, saying: "I have never attended any such ceremony in Kilburn, Karachi or Kathmandu. It is simply and categorically untrue." He went on to reiterate his position that religious beliefs are a "personal matter". His marriages to Dr Abu-Zayyad in 1994 and Rima Husseini in 2007 both took place in Muslim ceremonies. His wife since 2012, Putri Gayatri Pertiwi, is also Muslim. In March 2024, Galloway was sworn-in as an MP holding a copy of the Bible. In a Good Morning Britain interview, in April of the same year, Galloway stated he was "a practicing Roman Catholic".
Sources: en.wikipedia.org
Liquid chromatography with mass spectrometry is a common approach. Ultraviolet detection and nuclear magnetic resonance can support identification when suitable standards are available.
The solid is generally kept cold, dry, and protected from light. Solutions are often frozen in single-use aliquots to reduce repeated freeze-thaw cycles.
It indicates a material sold for laboratory study, not for human use. The label does not guarantee pharmaceutical purity, sterility, or regulatory approval.
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.